This is Queen Street Analytics' weekly digest of regulatory developments, legislative discussions and other government-related news concerning healthcare providers, doctors, physicians, clinicians, pharmacies and pharmacists, dental care providers, oral care providers, naturopaths, and old-age care providers. Once a week, we break down the most important updates in this space in under five minutes.

Dates: 2026-01-24 to 2026-01-30

📋 In This Week's Newsletter

• 🏛️ This Week's Congressional Calendar
• 📚 What We're Reading This Week

This Week's Congressional Calendar

• Common Schemes, Real Harm: Examining Fraud in Medicare and Medicaid: The House Energy and Commerce Subcommittee on Oversight and Investigations will convene a hearing to address fraudulent schemes affecting the Medicare and Medicaid programs on February 3, 2026, at 3:30 PM in Rayburn 2360.
• Senate Indian Affairs Committee to discuss Indian Health Care Improvement Act bills: The Senate Indian Affairs Committee will meet February 4, 2026, at 7:15 PM in Dirksen 628 to review S.2098, S.1055, and S.699 concerning property conveyance and modifications to the Indian Health Care Improvement Act notification and liability provisions.

What We're Reading This Week

• Opinion | Ro and Our New Health Sherpas: Commentary examines new models for health consumer navigation and access.
• The health care hiring boom is losing steam: U.S. health care job growth slows after period of rapid post-pandemic expansion.
• Abbott gets Europe’s CE mark for dual ablation catheter: Abbott secures European market approval for its dual ablation catheter device.
• Boston Scientific recalls stent over issue linked to 3 deaths: Boston Scientific issues recall of Axios stent following reported device-related fatalities.

.